Compensation and Royalties Sample Clauses

The Compensation and Royalties clause defines how and when payments are made to a party for the use of their intellectual property, services, or contributions. Typically, it outlines the structure of compensation, such as fixed fees, percentage-based royalties, or milestone payments, and may specify reporting requirements or payment schedules. This clause ensures that the rights holder is fairly remunerated for their work or assets, providing clarity and preventing disputes over financial entitlements.
POPULAR SAMPLE Copied 1 times
Compensation and Royalties. 7.1 In consideration for PHAGE’s assignment of a 50% ownership interest in all existing Patent Rights within the Field and its agreement to jointly hold all future Patent Rights within the Field, CARDIO agrees to either (at CARDIO’s sole discretion): (a) purchase FGF from PHAGE for 10% of CARDIO’s net sales price of finished Product to end customer or distributor; or (b) pay PHAGE a 6% royalty on the net sales price of finished Product to end customer or distributor, when said finished Product is produced by CARDIO or a third party under the jointly held Patent Rights. 7.2 CARDIO agrees to pay PHAGE for any Technical Development Services (Section 6) performed by PHAGE at CARDIO’s direction. Payment for such services will be limited to PHAGE’s actual cost of service including direct, indirect and overhead costs, but no profit component. Any such amounts will be billed to CARDIO on a monthly basis. Payments for Technical Development Services are in addition to compensation/royalties set forth in Section 7.1.
Compensation and Royalties. (a) Upon execution of this Agreement but not before $500,000 or more are raised for Licensee capitalization, Licensee shall pay to Licensor the sum of Fifty Thousand United States Dollars (US$50,000). (b) In addition to the aforesaid payment, Licensee shall pay to Licensor royalties in such amounts as, after deduction of all taxes, shall be equal to up to six percent (6%) of the net sales prices of such Products, as follows: (i) 1.5% of the sales if the Licensee’s end product uses only one Licensor’s patent; (ii) 3% of the sales if the Licensee’s end product uses two Licensor’s patents; (iii) 4.5% of the sales if the Licensee’s end product uses three Licensor’s patents; and (iv) 6% of the sales if the Licensee’s end product uses four or more Licensor’s patents. (c) In determining the quantities of the Products made, used or sold by Licensee and its affiliated companies for purposes of computing the royalties payable to Licensor in accordance with Paragraph (b) of this Article, no account shall be taken of any Products manufactured and sold by Licensor (or by any licensee of Licensor other than Licensee) to Licensee or its affiliated companies, and no royalty shall be payable with respect thereto. (d) As used above and throughout this Agreement, the termnet sales price” shall mean the amount invoiced by Licensee or its affiliated companies to unrelated third parties for the total number of the Products sold to such unrelated third parties. Such amount shall not include any allowances to such unrelated third parties, sales taxes or cost of packaging and packing. In the event that Licensee or its affiliated companies shall sell or ship the Products to related parties, it shall be deemed to have been sold at the net sales price which would be charged if the said Products had been sold or offered for sale to unrelated third parties in the same area. (e) If Licensee shall at any time grant any right by sublicense to any affiliated company in any area in the Licensed Territory to manufacture the Products in such area, Licensee shall require the affiliated company to pay royalties to Licensor on the same basis as set forth in Paragraph (b) of this Article. The quantity of the Products made, used or sold by such manufacturing affiliated company shall be calculated separately for the purpose of computing the amount of royalties payable by such affiliated company to Licensor on the basis as set forth in Paragraph (b) of this Article, and such quantity shall not be ...
Compensation and Royalties. There will be no financial compensation or royalties paid to the author for the submission or inclusion of the chapter in the Book.
Compensation and Royalties. 5.1 In consideration of the sublicense granted herein, Sublicensee shall pay Sublicensor an upfront sublicense fee of $1,700,000 USD ("Sublicense Fee") payable as stated in Section 5.2. 5.2 Sublicensee shall pay the Sublicense Fee within thirty (30) days following the Effective Date of this Agreement. 5.3 Sublicensee shall pay the following royalties: (i) $200 on the sale of each iLamp and (ii) 10% on all revenues derived from Power as a Service (PaaS) related to the licensed products. 5.4 Payment of royalties must occur within thirty (30) days following Sublicensee’s receipt of payment from third parties for the sale of the Licensed Products. 5.5 Royalties or any other payments received by Sublicensor after the due date shall bear interest at the rate of 18% per annum from the due date or the maximum rate permitted by law, if less than 18%.
Compensation and Royalties. In consideration for the License granted herein and for the services to be performed by ▇▇▇▇▇▇▇▇ hereunder, Virtual Dining shall pay to ▇▇▇▇▇▇▇▇ the following amounts:
Compensation and Royalties. The Licensee shall compensate the Editor as set forth in Addendum A. Royalties shall be payable quarterly, in arrears and Licensee shall provide a statement, signed by an officer of the Licensee, within 30 days of the end of each calendar quarter beginning after the Effective Date of this Agreement (March 31st, June 30th, September 30th, December 31st). The statement must indicate the term of any subscriptions claimed, units sold, and list price of units. All amounts herein refer to U.S. dollars. For bulk sales, a company name and sales contact shall be provided to enable the Editor to verify that the stated bulk sale was execute with the third party. Editor or their independent auditor will have the right to audit the relevant records of the Licensee.
Compensation and Royalties. No compensation or royalties are required from the Publication for the use of the Works as described herein.
Compensation and Royalties. 5.1 In consideration of the license granted herein, Licensee shall pay Licensor an upfront license fee of $5,000,000 USD ("License Fee"). 5.2 The Licensee has exercised an option to acquire the license and has paid $100,000 USD as an option fee. The License Fee payable by the Licensee shall be reduced by the amount of the option fee already paid. 5.3 Upon execution of this Agreement, the Licensee shall pay $300,000 USD toward the License Fee, which shall be non-refundable. 5.4 The remaining balance of the License Fee, after deducting the option fee and the deposit, shall be covered by a loan provided by Cede Capital ("Loan"). The terms and conditions of the Loan shall be set forth in a separate agreement between the Licensee and Cede Capital. 5.5 As collateral for the Loan, Cede Capital shall utilise asset custody services provided by ILOCX to hold the Licensing rights granted to the Licensee under this Agreement. The collateral shall remain with ILOCX until the Loan is fully paid in accordance with the terms of the Loan agreement. 5.6 Until the Loan is fully paid, any sublicensing of the licensed rights by the Licensee shall require the prior approval of Cede Capital. 5.7 The Licensee shall diligently make payments toward the Loan in accordance with the agreed-upon schedule and shall comply with all terms and conditions of the Loan agreement. 5.8 Licensee shall pay a royalty of $1,000 on the sale of each iLamp. 5.9 Licensee shall pay a royalty of 20% on all revenues derived from Power as a Service (PaaS) related to the licensed products. 5.10 Royalties or any other payments received by CPG after the due date shall bear interest at the rate of 18% per annum from the due date or the maximum rate permitted by law, if less than 18%. 5.11 Licensee may request changes to existing website, documents, PDFs, videos, or other work provided by CPG. Requested changes will be subject to compensation at our preferential rate for license partners. Licensee agrees to compensate CPG for any requested work performed by CPG or third parties contracted by CPG. Estimates for the costs can be provided upon request.
Compensation and Royalties a. The Author(s)/Editor(s) will receive royalties as indicated below after first 200 copies are sold: US/Canadian print sales: 10% on net sales to Apple Academic Press ROW sales: 10% on net sales to Apple Academic Press ebook sales: 10% on net sales to Apple Academic Press (ROW = rest of world) b. If there are multiple Author(s)/Editor(s), royalties will equally divided between all Author(s)/Editor(s) unless otherwise specified by the Author(s)/Editor(s) in writing. c. E-copies of the book (in pdf format) will be provided to the Author(s)/Editor(s) and any chapter contributors to the Work for their personal use and NOT to put online in any way after publication of the Work. d. No royalty will be paid on copies of the Work furnished gratis for review, advertising, promotion, bonus, sample, or like purposes, or on copies of the Work sold at less than Publisher’s cost, or on any copies returned to Publisher for any reason, or on copies of the Work sold to the Author. Free use of the rights granted herein may be made by the Publisher to promote the sale of copies of the Work and the rights therein. e. For purposes of this Agreement, the Publisher’s “net receipts” from sales shall mean monies received by the Publisher from such sales less adjustments for discounts, credits, and returns. Royalties will not be paid on prepaid transportation, postage, insurance, and taxes. The Publisher’s “net receipts” from licensing or assignment shall mean monies received by the Publisher less any specified costs of such licensing or assignment. f. All payments made under the terms of this Agreement will be subject to Federal income tax withholding, as required by the United States Internal Revenue Code. g. The Publisher will provide to the first Author/Editor an annual or biannual statement of sales made (hereinafter referred to as the “Statement”). These Statements will be rendered annually. Subject to the provisions of this Agreement, the Statement will be accompanied by a check or funds electronically deposited into bank accounts for Editor(s)/Author(s) for any monies shown to be due by such Statement. If less than fifty dollars ($50.00) (OR one-hundred dollars ($100.00) for an electronic payment) is shown to be due in any Accounting Period, the Publisher may defer payment thereof until the next period in which fifty dollars ($50.00) (or one-hundred dollars ($100.00) if an electronic payment) or more is shown to be due. The Publisher reserves the right to deduct from paymen...
Compensation and Royalties. 4.1 During the continuance, and in further consideration, of the rights and licenses granted hereunder, DUSA agrees to pay to PARTEQ a fee of fifty thousand Canadian dollars (CA$50,000.00), (or one hundred thousand Canadian dollars (CA $100,000) if by the payment due date hereof DUSA has entered into a sublicense agreement as defined in Section 4.5.2 below) within thirty (30) days of the receipt by DUSA or sublicensee hereunder of approval from the United States Food and Drug Administration to market Products in the United States of America. 4.2 PARTEQ acknowledges that it has received from DUSA CA$150,000.00 and that pursuant to Section 4.4 of the Original License, such fees shall be deducted from any royalties payable pursuant to Sections 4.3 and 4.12 hereof; provided, however, that the credit shall not exceed CA$75,000 in any year, and further provided that the credit shall be taken only to the extent that royalties payable under Section 4.3 exceed the minimum royalties specified in Section 4.12 (e.g., to obtain a credit of CA$75,000 in year 1, royalties under Section 4.3 would have to equal or exceed CA$125,000).